Back to home
Technology

A new way to rejuvenate the immune system

Source

MIT Technology Review

Published

TL;DR

AI Generated

Researchers at MIT and the Broad Institute have discovered a new method to rejuvenate the immune system by stimulating the liver to produce signals that typically come from the thymus. By encoding key factors promoting T-cell maturation into mRNA sequences delivered via lipid nanoparticles, the liver can be temporarily programmed to enhance T-cell function. In aged mice, this treatment led to larger and more diverse T-cell populations, resulting in improved responses to vaccination and cancer immunotherapy. If this approach is successful in humans, it could potentially help individuals maintain better health and disease resistance as they age.

Read Full Article

Similar Articles

MIT Technology Review

The Download: how humans make decisions, and Moderna’s “vaccine” word games

The article discusses how humans make decisions, with Uri Maoz, a professor of computational neuroscience, exploring the connection between desires, beliefs, and actions. Moderna's use of mRNA technology for cancer treatment is causing a debate over whether to label it a "vaccine" or "therapy." The company's decision to rebrand it as an "individualized neoantigen therapy" aims to avoid vaccine-related controversies. Additionally, the article highlights other tech news, including attacks on Sam Altman's home, the AI arms race, and Apple's development of smart glasses.

MIT Technology Review
MIT Technology Review

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

Moderna is facing a dilemma over whether to call its cancer treatment a "vaccine" or a "therapy" to distance itself from vaccine skepticism. The company's mRNA technology is being used in partnership with Merck to develop individualized neoantigen therapy for cancer treatment. Despite the promising results, some are concerned that patients may be misled by the terminology change. Moderna's strategy to rebrand its cancer treatment may be a response to government scrutiny over its mRNA vaccines. The debate over terminology reflects the broader challenges in navigating public perception and regulatory hurdles in the biotech industry.

MIT Technology Review
MIT Technology Review

Reformulated antibodies could be injected for easier treatment

Researchers have developed a method to reformulate therapeutic antibodies into microparticles that can be injected with a standard syringe, eliminating the need for lengthy infusions. By encapsulating antibodies into hydrogel particles using a microfluidic setup, they achieved highly concentrated solid antibodies that can be easily administered. The new formulation allows for the injection of over 700 milligrams of antibodies with a two-milliliter syringe, and the stability of the formulations was maintained for at least four months under refrigeration. Further testing in animals and scaling up the manufacturing process are the next steps for this promising development in antibody treatment.

MIT Technology Review
Dr. L.C. Lu on TSMC Advanced Technology Design Solutions

Dr. L.C. Lu on TSMC Advanced Technology Design Solutions

Dr. L.C. Lu, a key figure at TSMC, focuses on design-technology co-optimization, packaging innovations, and AI-driven methodologies for next-gen semiconductor systems. TSMC emphasizes DTCO and DDCL innovations for scaling from N5 to A14 nodes, with NanoFlex and NanoFlex Pro architectures offering efficiency gains. N2P and N2U nodes incorporate advanced DTCO and power delivery optimizations, with hybrid dual-rail architectures achieving significant energy savings. TSMC collaborates with EDA partners for AI integration, enhancing productivity and design quality. Advanced packaging technologies like CoWoS and SoIC play a crucial role in enabling AI scaling, with memory bandwidth and interconnect performance scaling aggressively. TSMC addresses power delivery and thermal management challenges in AI systems through advanced solutions. TSMC's advancements in design methodologies and AI-driven automation promise improved productivity and scalability in chip-package co-design.

SemiWiki

We use cookies

We use cookies to ensure you get the best experience on our website. For more information on how we use cookies, please see our cookie policy.